Small Business Innovation Research · Small Business Technology Transfer

Lumen Bioscience, Inc.: SBIR & STTR awards

3 awards worth $3.62M to 1 companies since 2018 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).

Lumen Bioscience, Inc.'s federal contracts and grants · All SBIR & STTR awards

Clear

Awards by year

YearPhase IPhase IIAmount
202101$2.93M
201820$696.5K

The latest year fills in over months: agencies report awards to SBIR.gov with a lag.

By agency

Latest matching awards

AwardCompanyAgencyPhaseAmountDate
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine. · topic NIAIDLumen Bioscience, Inc. · WashingtonDepartment of Health and Human Services · National Institutes of HealthSTTR Phase II$2.93M2021-07-19
Spirulina-based oral vaccine for infectious hematopoietic necrosis virus (IHNV) in farmed salmonid fish · topic 8.7Lumen Bioscience, Inc. · WashingtonDepartment of AgricultureSBIR Phase I$99.6K2018-07-01
Development of a Spirulina-based oral malaria vaccine · topic NIAIDLumen Bioscience, Inc. · WashingtonDepartment of Health and Human Services · National Institutes of HealthSTTR Phase I$597.0K2018-05-17

Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.